Medicines from cancer : scientists happy

American scientists have developed an anti-cancer drug known as 2S4 or Omnitarg, as a result of clinical trials proved to be one of the best known to date drugs of this type.

After receiving his spirits dramatically improved patients late stage lung cancer, prostate, breast, ovary and connective tissue. The drug, a protein which sharply intensifying the immune system of patients. However, officially the effectiveness of new drugs has no one spoke. An only the first stage of testing, which primarily to define how the drug is safe. The los-anzhelesskogo Medical Center Cedars David Agus told the press : "This drug actually worked on the tumor directly, and their size reduced."

First results
A clinical trial of its intravenous drugs to more than 20 patients. The experiment continued for about three weeks. The 42% of patients or reduced the size of tumors by 50%, or stopped growing. The three patients was partial remission, which has continued for several months. The five patients had stabilized. David Agus considers such spectacular results. "All of our patients have taken the drug already in the latter stages of cancer, when no other therapeutic techniques are no longer useful," he said. However, his colleague from the British Cancer Research Fund UK Elaine Vickers calls bit : "The drug was only a small number of patients, and to be confident about the effectiveness of the drugs so far."